Georg Rüedi
Co-Founder & CEO @ Nanolynx Biologics AG
About
Biotech entrepreneur committed to transforming cutting-edge science and technology into impactful therapies that address unmet medical needs. With deep experience in discovery and preclinical development, I combine scientific insight with operational leadership to build high-performing organizations.
Switzerland
Basel Metropolitan Area
Pharmaceuticals
Antibiotics, Fundraising, Operational Excellence, Business Strategy, Biotechnology, Technology Integration, Automation, High Throughput, Customer Satisfaction, Business Process Improvement, Creativity and Innovation, Cement, High Temperature, Continuous Process Improvement, Green Technology, Matrix Leadership, Drug Discovery, Medicinal Chemistry, Synthetic Organic Chemistry, Intellectual Property
Experience
Co-Founder & CEO
Nanolynx Biologics AG
Basel Metropolitan Area
Nanolynx is pioneering first-in-class conditionally active nanobody-drug conjugates for hard-to-treat solid tumors.
Board Member
Stiftung FHNW
CSO
molab.ai
Munich, Germany
Senior Director, Head of Chemistry Technologies and Process R&D
Idorsia Pharmaceuticals Ltd
Basel, Switzerland
Managing director of a synthesis and technology department with operational and strategic leadership responsibilities including: - Digitalization, robotics and lab automation - Library synthesis, enabling and green chemistries - IND-enabling API batch production and tech transfer to CDMOs - Analytics, purification & method development - External alliances with CROs, pharma/biotech and academic institutions - Financial planning and analysis
Senior Director, Head of Chemistry Technologies and Lead Discovery
Idorsia Pharmaceuticals Ltd
Managing director of a science and technology group with operational and strategic leadership responsibilities including: - Hit finding (drug modalities, corporate library and screening technologies) - Lead discovery (hit-to-lead chemistry, early discovery pipeline) - Computer-aided drug design (CADD) - AI/ML-driven drug design and discovery strategy - Scientific computing - Analytics, purification & method development - Scientific project evaluation across therapeutic areas
Director, Head of Anti-infectives Chemistry
Actelion (now Janssen Pulmonary Hypertension)
Basel, Switzerland
Research group leader (20+ people) in antibiotic drug discovery with operational and strategic responsibilities including: - Portfolio Management - Competitive intelligence and due diligence - Intellectual property and patent strategy - Scientific project evaluation across therapeutic areas - Public private partnerships and fundraising - Outsourcing, budgeting and resource allocation
Research Scientist, Medicinal Chemistry
Actelion (now Janssen Pulmonary Hypertension)
Lab head in hit-to-lead and lead optimization projects (up to three technicians/associates/trainees) - Project leadership experience in cross-functional matrix organizations - Key expertise in total synthesis and scale up of complex antibiotics - Prodrug strategy and formulation development - Intellectual property and patent writing
Education
Stanford University
Bioorganic Chemistry
Harvard Business School
Executive Education, Leadership and Negotiation
University of Zurich
Organic Chemistry (Methodology)
University of Zurich
Organic Chemistry (Synthesis)
Georg Rüedi's Contact Information
Phone
Find the Right Leads
Find Verified Contact Data
What LeadContact does well
Find verified emails, phone numbers, and decision-makers with 98% accuracy.
Find Leads
Find the right people by company, role, industry, location, and more.
925M+ professional profiles
Find Emails
Access verified email addresses for your target contacts.
657M+ emails
Find Phone Numbers
Get cross-validated phone data from multiple top sources.
239M+ phone numbers
More Accurate. Lower Cost.
Find contact data in 1 tool with 98% accuracy
LeadContact integrates leading enrichment tools to deliver more accurate contact data—without paying for each one.
Great conversations start with the right contact.
It’s time to find yours.